| The diverse roles of anticonvulsants in bipolar disorders. | |
| | |
MedLine Citation:
|
PMID: 12938867 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Anticonvulsant drugs (ACs) have diverse antiseizure, psychotropic, and biochemical effects. Carbamazepine and valproate have mood-stabilizing actions, benzodiazepines and gabapentin have anxiolytic actions, lamotrigine is useful in rapid cycling and acute treatment and prophylaxis of bipolar depression, and topiramate and zonisamide can yield weight loss. Limited controlled data suggest the carbamazepine keto derivative oxcarbazepine has antimanic effects. A categorical approach to the diverse roles of ACs in bipolar disorders is proposed, using broad categories of ACs, on the basis of their predominant psychotropic profiles. Thus, some ACs have "sedating" profiles that may include sedation, cognitive difficulties, fatigue, weight gain, and possibly antimanic and/or anxiolytic effects. In contrast, some newer ACs have "activating" profiles that may include improved energy, weight loss, and possibly antidepressant and even anxiogenic effects. Still other newer ACs have novel "mixed" profiles, combining sedation and weight loss. A categorical-mechanistic extension of this approach is also presented, with hypotheses that "sedating" profiles might be related to prominent potentiation of gamma-aminobutyric acid (GABA) inhibitory neurotransmission, "activating" profiles could be related to prominent attenuation of glutamate excitatory neurotransmission, and for "mixed" profiles, sedation and weight loss might be related to concurrent GABAergic and antiglutamatergic actions, respectively. The categorical approach may have utility as an aid to clinicians in reinforcing the heterogeneity ACs, and recalling psychotropic profiles of individual ACs, but is limited as it fails to address the etiology of the heterogeneity of AC psychotropic effects. The categorical-mechanistic extension strives to address this issue, but requires systematic clinical investigation of more precise relationships between psychotropic profiles and discrete mechanisms of action to assess its merits. |
| | |
Authors:
|
Terence A Ketter; Po W Wang; Olga V Becker; Cecylia Nowakowska; Yen-Shou Yang |
Related Documents
:
|
549437 - The comparative influence of gamma-hydroxy butyric acid, althesin and etomidate on the ... 75177 - The requirement of specific antibody for the killing of e. coli by the alternate comple... 6146137 - The ferrier lecture, 1983. amino acids and peptides: fast and slow chemical signals in ... 6834037 - Anticonvulsant activity of glycylglycine and delta-aminovaleric acid: evidence for glut... 2352167 - Synthesis and biological activity of a series of aspartate transcarbamoylase inhibitors... 15721987 - Human fecal water content of phenolics: the extent of colonic exposure to aromatic comp... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists Volume: 15 ISSN: 1040-1237 ISO Abbreviation: Ann Clin Psychiatry Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-08-26 Completed Date: 2003-12-12 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8911021 Medline TA: Ann Clin Psychiatry Country: United States |
Other Details:
|
Languages: eng Pagination: 95-108 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305-5723, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Affect
/
drug effects Anticonvulsants / therapeutic use* Bipolar Disorder / drug therapy*, metabolism, psychology Brain / drug effects, metabolism Humans Neurotransmitter Agents / metabolism Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anticonvulsants; 0/Neurotransmitter Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neurobiology of bipolar illness: implications for future study and therapeutics.
Next Document: Ginkgo biloba extract: review of CNS effects.